Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
Helian Feng(Harvard University), Jenny Chang‐Claude(Universität Hamburg), Qiuyin Cai(Vanderbilt University), Volker Arndt(German Cancer Research Center), Hiltrud Brauch(German Cancer Research Center), Zomoroda Abu-Full(Carmel Medical Center), Sander Canisius(University of Cambridge), Natalia Bogdanova(Medizinische Hochschule Hannover), Banu Arun(The University of Texas Health Science Center at Houston), Thomas Brüning(Institute for Prevention and Occupational Medicine), Ana Blanco(Fundación Pública Galega de Medicina Xenómica), Jose E. Castelao(Servicio Gallego de Salud), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Annegien Broeks, Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Ian Campbell(The University of Sydney), Antonis C. Antoniou(Weatherford College), Daniel Barrowdale(University of Cambridge), Matthias W. Beckmann(Universitätsklinikum Erlangen), Alexander Gusev(Dana-Farber Cancer Institute), Aðalgeir Arason(University of Iceland), Irene L. Andrulis(University of Toronto), Katarzyna Białkowska(International Hereditary Cancer Center), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Daniel R. Barnes(University of Cambridge), Bogdan Paşaniuc(Translational Therapeutics (United States)), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lang Wu(University of Hawaiʻi at Mānoa), Carl Blomqvist(University of Helsinki), Brian D. Carter(American Cancer Society), Rósa B. Barkardóttir(University of Iceland), Daniele Campa(University of Pisa), Ignacio Briceño(Universidad de La Sabana), Stig E. Bojesen(University of Copenhagen), Ella Asseryanis(Comprehensive Cancer Center Vienna), Hermann Brenner(Universidad de Granada), Jonathan Carter(University of California, San Francisco), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Bram Boeckx(VIB-KU Leuven Center for Cancer Biology), Judith Balmañà(Vall d'Hebron Hospital Universitari), Kristan J. Aronson(Queen's University), Jirong Long(Vanderbilt University Medical Center), Barbara Burwinkel(German Cancer Research Center), Kristiina Aittomäki(University of Helsinki), Åke Borg(Lund University), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Manjeet K. Bolla(University of Cambridge), Marina Bermisheva(Russian Academy of Sciences)
Cited by 45
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Integrative approaches for large-scale transcriptome-wide association studies
|Nature Genetics|2016|2.7k